The function of CD44+/CD24−/low cells in BC was demonstrated in samples of nine patients, where they were showed to induce tumor development in NOD/SCID mice, in contrast to the use of cells with a different immunophenotype [7]. This evidence concerns the gene CD44 and breast cancer.